Search research articles
Contact Us
Filters
Showing results (31-40 of 95) with videos related to
Page
of 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 3, 2016
Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks
Anthony McDonnell, John H Rex, Herman Goossens, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Combination antifungal therapy
Melissa D Johnson, Conan MacDougall, Luis Ostrosky-Zeichner, et al.
Nature Reviews. Drug Discovery
|
August 21, 2010
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner, Arturo Casadevall, John N Galgiani, et al.
Nature Communications
|
August 2, 2019
Designing development programs for non-traditional antibacterial agents
John H Rex, Holly Fernandez Lynch, I Glenn Cohen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus
Corinne Pinder, Mike Birch, Jason D Oliver, et al.
Nature Reviews. Microbiology
|
November 21, 2019
Antibiotic development - economic, regulatory and societal challenges
Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan, et al.
Health Policy (Amsterdam, Netherlands)
|
September 11, 2017
Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
Adrian Towse, Christopher K Hoyle, Jonathan Goodall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2004
The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview
John H Rex, John R Wingard, Richard Wenzel, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2002
Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro
Jean-Sébastien Ripeau, Francine Aumont, Pierre Belhumeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2020
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics
Helen W Boucher, Thomas M File, Vance G Fowler, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 95) with videos related to
Sort By:
Page
of 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 3, 2016
Efficient Delivery of Investigational Antibacterial Agents via Sustainable Clinical Trial Networks
Anthony McDonnell, John H Rex, Herman Goossens, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Combination antifungal therapy
Melissa D Johnson, Conan MacDougall, Luis Ostrosky-Zeichner, et al.
Nature Reviews. Drug Discovery
|
August 21, 2010
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner, Arturo Casadevall, John N Galgiani, et al.
Nature Communications
|
August 2, 2019
Designing development programs for non-traditional antibacterial agents
John H Rex, Holly Fernandez Lynch, I Glenn Cohen, et al.
The Journal of Antimicrobial Chemotherapy
|
March 31, 2026
Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus
Corinne Pinder, Mike Birch, Jason D Oliver, et al.
Nature Reviews. Microbiology
|
November 21, 2019
Antibiotic development - economic, regulatory and societal challenges
Christine Årdal, Manica Balasegaram, Ramanan Laxminarayan, et al.
Health Policy (Amsterdam, Netherlands)
|
September 11, 2017
Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
Adrian Towse, Christopher K Hoyle, Jonathan Goodall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2004
The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview
John H Rex, John R Wingard, Richard Wenzel, et al.
Antimicrobial Agents and Chemotherapy
|
August 17, 2002
Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro
Jean-Sébastien Ripeau, Francine Aumont, Pierre Belhumeur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 31, 2020
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics
Helen W Boucher, Thomas M File, Vance G Fowler, et al.
Page
of 10